We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$78.9B
AUM Growth
+$522M
Cap. Flow
+$1.98B
Cap. Flow %
2.5%
Top 10 Hldgs %
13.37%
Holding
702
New
56
Increased
268
Reduced
333
Closed
31

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$552M
2
BA icon
Boeing
BA
+$226M
3
ORCL icon
Oracle
ORCL
+$190M
4
CB icon
Chubb
CB
+$176M
5
NVS icon
Novartis
NVS
+$172M

Sector Composition

Rank Sector Weight
1 Financials 21.51%
2 Industrials 14.85%
3 Technology 14.38%
4 Healthcare 14.3%
5 Consumer Discretionary 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNP icon
126
Union Pacific
UNP
$183B
$218M 0.28%
1,108,960
+256,983
+30% +$55.5M
CUZ icon
127
Cousins Properties
CUZ
$5.29B
$215M 0.27%
5,760,984
+103,744
+2% +$4M
HAS icon
128
Hasbro
HAS
$12.6B
$214M 0.27%
2,400,116
+628,083
+35% +$61M
ULTA icon
129
Ulta Beauty
ULTA
$20.4B
$214M 0.27%
591,649
+17,224
+3% +$6.22M
AFL icon
130
Aflac
AFL
$63.9B
$212M 0.27%
4,073,712
-2,103,164
-34% -$115M
ALSN icon
131
Allison Transmission
ALSN
$10.1B
$212M 0.27%
5,997,322
-2,376,325
-28% -$90.7M
CNXC icon
132
Concentrix
CNXC
$1.36B
$211M 0.27%
1,187,925
-25,442
-2% -$4.22M
EVTC icon
133
Evertec
EVTC
$1.83B
$210M 0.27%
4,597,773
+92,809
+2% +$4.19M
PGR icon
134
Progressive
PGR
$124B
$210M 0.27%
2,327,581
-759,292
-25% -$72.4M
MRK icon
135
Merck
MRK
$324B
$210M 0.27%
2,789,532
+151,945
+6% +$11.6M
HCA icon
136
HCA Healthcare
HCA
$84.8B
$208M 0.26%
855,613
+19,642
+2% +$4.8M
FLEX icon
137
Flex
FLEX
$43.4B
$207M 0.26%
15,504,181
+433,658
+3% +$5.83M
MOS icon
138
The Mosaic Company
MOS
$7.09B
$207M 0.26%
5,781,283
-731,291
-11% -$23.4M
TPR icon
139
Tapestry
TPR
$28.8B
$206M 0.26%
5,574,003
-1,808,948
-25% -$74.4M
GL icon
140
Globe Life
GL
$13.5B
$204M 0.26%
2,290,500
+65,420
+3% +$6.11M
ITT icon
141
ITT
ITT
$17.5B
$203M 0.26%
2,365,395
-237,570
-9% -$22.3M
WDC icon
142
Western Digital
WDC
$179B
$202M 0.26%
4,728,124
+82,403
+2% +$3.91M
ALL icon
143
Allstate
ALL
$66.9B
$202M 0.26%
1,583,880
+80,130
+5% +$10.6M
RNR icon
144
RenaissanceRe
RNR
$13.7B
$195M 0.25%
1,396,475
+70,874
+5% +$10.7M
SLM icon
145
SLM Corp
SLM
$4.57B
$194M 0.25%
11,003,776
-2,341,164
-18% -$44M
TRV icon
146
Travelers Companies
TRV
$80.8B
$194M 0.25%
1,274,355
+40,619
+3% +$6.29M
ESS icon
147
Essex Property Trust
ESS
$18.9B
$193M 0.24%
604,640
+16,832
+3% +$5.45M
HXL icon
148
Hexcel
HXL
$8.32B
$192M 0.24%
3,230,553
+72,400
+2% +$4.18M
EXPD icon
149
Expeditors International
EXPD
$22.9B
$191M 0.24%
1,601,132
+49,873
+3% +$6.24M
AIMC
150
DELISTED
Altra Industrial Motion Corp
AIMC
$189M 0.24%
3,406,001
+69,768
+2% +$4.16M

Similar funds

Boston Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Boston Partners held 702 positions worth $78.9B, up 0.67% from $78.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q3 2021 filing shows 56 new, 268 increased, 333 reduced and 31 closed positions. Its largest new stake was Global Payments: 2,796,841 shares worth $441M. The largest sale was Elevance Health, an estimated $552M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

  • Boston Partners's largest Q3 2021 buy was Global Payments: 2,796,841 shares worth $441M.
  • Boston Partners added most to Activision Blizzard in Q3 2021, an estimated $314M increase.
  • Boston Partners's biggest Q3 2021 reduction was Elevance Health, cutting an estimated $552M.
  • Boston Partners fully exited Cummins in Q3 2021, selling an estimated $161M.
  • Boston Partners's ten largest holdings make up 13% of its $78.9B portfolio in Q3 2021.
  • Boston Partners opened 56 new positions and closed 31 in Q3 2021.
  • Boston Partners's portfolio value rose 0.67% quarter-over-quarter to $78.9B.

Based on Boston Partners's 13F filing for Q3 2021, filed 5 Nov 2021.